Ordering Recommendation
Adjunct test for the investigation of hyperandrogenic and adrenal disorders. Not recommended for initial evaluation of polycystic ovarian syndrome.
Mnemonic
Methodology
Quantitative High Performance Liquid Chromatography-Tandem Mass Spectrometry
Performed
Sun-Sat
Reported
1-4 days
New York DOH Approval Status
Specimen Required
Collect between 6-10 a.m.
Serum separator tube or green (sodium or lithium heparin). Also acceptable: Lavender (EDTA).
Separate serum or plasma from cells ASAP or within 2 hours of collection. Transfer 1 mL serum or plasma to an ARUP Standard Transport Tube. (Min: 0.3 mL)
Refrigerated.
After separation from cells: Ambient: 24 hours; Refrigerated: 1 week; Frozen: 6 months
Reference Interval
Effective August 19, 2013
Age | Female | Male |
---|---|---|
Premature | Less than 40 ng/mL | Less than 40 ng/mL |
0-1 day | Less than 11 ng/mL | Less than 11 ng/mL |
2-6 days | Less than 8.7 ng/mL | Less than 8.7 ng/mL |
7 days-1 month | Less than 5.8 ng/mL | Less than 5.8 ng/mL |
1-5 months | Less than 2.9 ng/mL | Less than 2.9 ng/mL |
6-24 months | Less than 1.9 9 ng/mL | Less than 2.5 ng/mL |
2-3 years | Less than 0.85 ng/mL | Less than 0.63 ng/mL |
4-5 years | Less than 1.03 ng/mL | Less than 0.95 ng/mL |
6-7 years | Less than 1.79 ng/mL | 0.06-1.93 ng/mL |
8-9 years | 0.14-2.35 ng/mL | 0.10-2.08 ng/mL |
10-11 years | 0.43-3.78 ng/mL | 0.32-3.08 ng/mL |
12-13 years | 0.89-6.21 ng/mL | 0.57-4.10 ng/mL |
14-15 years | 1.22-7.01 ng/mL | 0.93-6.04 ng/mL |
16-17 years | 1.42-9.00 ng/mL | 1.17-6.52 ng/mL |
18-39 years | 1.33-7.78 ng/mL | 1.33-7.78 ng/mL |
40 years and older | 0.63-4.70 ng/mL | 0.63-4.70 ng/mL |
Postmenopausal | 0.60-5.73 ng/mL | Does Not Apply |
Tanner Stage I | 0.14-2.76 ng/mL | 0.11-2.37 ng/mL |
Tanner Stage II | 0.83-4.87 ng/mL | 0.37-3.66 ng/mL |
Tanner Stage III | 1.08-7.56 ng/mL | 0.75-5.24 ng/mL |
Tanner Stage IV-V | 1.24-7.88 ng/mL | 1.22-6.73 ng/mL |
Interpretive Data
This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the US Food and Drug Administration. This test was performed in a CLIA certified laboratory and is intended for clinical purposes.
Laboratory Developed Test (LDT)
Note
Hotline History
CPT Codes
82626
Components
Component Test Code* | Component Chart Name | LOINC |
---|---|---|
2001641 | Dehydroepiandrosterone by TMS | 2193-1 |
Aliases
- DHEA (Dehydroepiandrosterone, Serum or Plasma)
- Unconjugated DHEA (Dehydroepiandrosterone, Serum or Plasma)